Publication:
Interleukin-2, interleukin-6 and T regulatory cells in peripheral blood of patients with Behcet's disease and recurrent aphthous ulcerations

dc.contributor.authorNAMDAR PEKİNER, FİLİZ MEDİHA
dc.contributor.authorBORAHAN, MEHMET OĞUZ
dc.contributor.authorsPekiner, Filiz Namdar; Aytugar, Emre; Demirel, Gulderen Yanikkaya; Borahan, Mehmet Oguz
dc.date.accessioned2022-03-12T18:05:48Z
dc.date.accessioned2026-01-10T18:39:31Z
dc.date.available2022-03-12T18:05:48Z
dc.date.issued2012
dc.description.abstractBACKGROUND: One of the factors involved in the pathogenesis of Behcet disease (BD) and recurrent aphthous ulcerations (RAU) is a cell-mediated immune response in which several cytokines (interleukin-2, interleukin-6) and T regulatory cell (T reg cell) population seem to play a major role. The aim of this study was to measured the interleukin-2 (IL-2), interleukin-6 (IL-6) levels and analysis of CD4(+) CD25(+) Foxp-3(+) Treg cells in peripheral blood from patients with BD and RAU. In addition; we also analysed peripheral blood from healthy subjects for comparison. METHODS: Thirty patients (15 men and 15 women) with BD, 30 patients (12 men and 18 women) with RAU and 15 healthy control subjects (nine men and six women) participated in the study. Analysis of CD4(+) CD25(+) Foxp-3(+) Treg cells, IL-2 and IL-6 levels have been measured in flow cytometry. RESULTS: No statistical differences were observed in the serum levels of IL-2 and IL-6 between BD and RAU patients, and healthy subjects. Although there were no statistical differences in the number of CD4(+) CD25(+) Foxp-3(+) cells between groups, there were statistically significant differences in the number of CD4(+) CD25(bright) Treg cells. CD4(+) CD25(bright) Treg cells were significantly increased in BD and RAU patients compared to healthy subjects. Statistical analysis revealed no difference according to the number of CD4(+) CD25(bright) cells between BD and RAU patients. CONCLUSIONS: These results indicate that CD4(+) CD25(bright) T regulatory cells may be contributing factor in the pathogenesis of BD and RAU. J Oral Pathol Med (2012) 41: 7379
dc.identifier.doi10.1111/j.1600-0714.2011.01061.x
dc.identifier.eissn1600-0714
dc.identifier.issn0904-2512
dc.identifier.pubmed21736625
dc.identifier.urihttps://hdl.handle.net/11424/230776
dc.identifier.wosWOS:000298838400012
dc.language.isoeng
dc.publisherWILEY
dc.relation.ispartofJOURNAL OF ORAL PATHOLOGY & MEDICINE
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectBehcet's disease
dc.subjectcytokine
dc.subjectIL-2
dc.subjectIL-6
dc.subjectrecurrent aphthous ulcerations
dc.subjectT regulatory cell
dc.subjectNECROSIS-FACTOR-ALPHA
dc.subjectIMMUNOLOGICAL-TOLERANCE
dc.subjectTNF-ALPHA
dc.subjectEXPRESSION
dc.subjectCYTOKINES
dc.subjectIL-6
dc.subjectRECEPTOR
dc.subjectLESIONS
dc.subjectFOXP3
dc.subjectGAMMA
dc.titleInterleukin-2, interleukin-6 and T regulatory cells in peripheral blood of patients with Behcet's disease and recurrent aphthous ulcerations
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage79
oaire.citation.issue1
oaire.citation.startPage73
oaire.citation.titleJOURNAL OF ORAL PATHOLOGY & MEDICINE
oaire.citation.volume41

Files